5-(1-Piperidinylmethyl)thiophene-2-boronic acid pinacol ester
Product Information
Molecular Formula
C16H26BNO2S
Molecular Weight
307.3
Description
5-(1-Piperidinylmethyl)thiophene-2-boronic acid pinacol ester, with its exceptional structural attributes, assumes a pivotal part in the formulation of pharmaceuticals targeting diverse afflictions such as cancer, inflammation, and neurological disorders. The versatility of this compound renders it an indispensable asset, fostering the advancement of innovative therapeutic remedies by researchers and pharmaceutical enterprises.
Synonyms
1-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl]methyl]piperidine; 1218790-44-3; 5-(1-Piperidinylmethyl)thiophene-2-boronicacidpinacolester; 1-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)methyl)piperidine; 5-((Piperidine)methyl)-2-thiopheneboronicacidpinacolester; AMTB125
IUPAC Name
1-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl]methyl]piperidine
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(S2)CN3CCCCC3
InChI
InChI=1S/C16H26BNO2S/c1-15(2)16(3,4)20-17(19-15)14-9-8-13(21-14)12-18-10-6-5-7-11-18/h8-9H,5-7,10-12H2,1-4H3
InChI Key
KDPVLCCGXRCQCV-UHFFFAOYSA-N
Melting Point
64-68 °C
Flash Point
Not applicable
Purity
95%
Safety Information
Hazards
H413
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
3
Exact Mass
307.1777304 g/mol
Monoisotopic Mass
307.1777304 g/mol
Topological Polar Surface Area
49.9Ų
Heavy Atom Count
21
Formal Charge
0
Complexity
355
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113336751-A | High-efficiency salt-induced kinase inhibitor and preparation method thereof | 2021-05-31 |
| EA-035173-B1 | DERIVATIVES OF ISOCHROME AS PHOSPHOINOSITIDE-3-KINAZ INHIBITORS | 2013-12-18 |
| EP-3083617-B1 | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | 2013-12-18 |
| US-2015166549-A1 | Isochromene derivatives as phoshoinositide 3-kinases inhibitors | 2013-12-18 |
| US-9321776-B2 | Isochromene derivatives as phoshoinositide 3-kinases inhibitors | 2013-12-18 |
| JP-6248123-B2 | Substituted 1H-pyrrolo [2,3-b] pyridine and 1H-pyrazolo [3,4-b] pyridine derivatives as salt-inducible kinase 2 (SIK2) inhibitors | 2012-12-14 |
| US-2014256704-A1 | Substituted 1H-Pyrrolo [2, 3-b] pyridine and 1H-Pyrazolo [3, 4-b] pyridine Derivatives as Salt Inducible Kinase 2 (SIK2) Inhibitors | 2012-12-14 |
| WO-2014093383-A1 | Substituted 1h-pyrrolo [2,3-b] pyridine and 1h-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (sik2) inhibitors | 2012-12-14 |
| EP-2726479-A1 | Novel inhibitor compounds of phosphodiesterase type 10a | 2011-06-30 |
| US-2013005705-A1 | Novel inhibitor compounds of phosphodiesterase type 10a | 2011-06-30 |
